GENE ONLINE|News &
Opinion
Blog

Synthetic Biology
Synthetic Biology’s Innovator Dr. John Cumbers – Addressing Inefficiencies in Biopharma and Economic Sustainability
2024-07-11
Ginkgo Job Cuts Expected to Affect at Least 35% of Workforce, Eliminating Over 400 Jobs
2024-07-02
Nucleate Taiwan Bridging Academia and Industry in the Field of Synbio
2024-07-02
Pearl Bio Enters $1 Billion Partnership Agreement with MSD for Biologic Therapies
2024-03-13
Refactoring Genetic Code to Create a “Firewall” for Bacteria
2022-10-27
Glowing Yeast and CBD; Biosensing at Boston College
2022-10-27
Leveraging Synthetic Biology, Microbiome-based Therapies Open Up Possibilities for Clinical Applications
2022-10-20
Synthetic Biology: A Rising Interdisciplinary Field that Revolutionizes the Biomedical Industry
2022-10-19
Bacteria-Derived Protocells Mark Breakthrough in Synthetic Biology
2022-09-23
LATEST
Accelerated Bio and Pluristyx Generate Clinical-Grade Induced Pluripotent Stem Cells from Reprogrammed Human Trophoblast Stem Cells
2024-07-12
Novo Nordisk and PT Bio Farma Agree to Enhance Insulin Production for Diabetes Patients in Indonesia
2024-07-12
Alzheimer’s Drug LEQEMBI Approved for Treatment in Hong Kong
2024-07-12
Foreseen Biotech Strikes $1.03B Deal with Ipsen for First-in-Class ADC
2024-07-12
Delivering Affordable Biologic Medicines Worldwide: An Interview with Tanvex Chairman and CEO, Henry Chen
2024-07-11
Roche Secures CE Mark for AI-Powered Glucose Monitoring Solution, Enhancing Diabetes Care with Predictive Insights
2024-07-11
$115M Series A Boosts Myricx Bio’s ADC Development with Lilly and Novo Support
2024-07-11
EVENT
Scroll to Top